References
- TakahashiKHiranoYArakiSHattoriMEmulsifying ability of porphyran prepared from dried nori, Porphyra yezoensis, a red algaJ Agric Food Chem20004872721272510898612
- IsakaSChoKNakazonoSAntioxidant and anti-inflammatory activities of porphyran isolated from discolored nori (Porphyra yezoensis)Int J Biol Macromol201574687525499893
- WangJZhangQZhangZSongHLiPPotential antioxidant and anticoagulant capacity of low molecular weight fucoidan fractions extracted from Laminaria japonicaInt J Biol Macromol201046161219883681
- RupérezPAhrazemOLealJAPotential antioxidant capacity of sulfated polysaccharides from the edible marine brown seaweed Fucus vesiculosusJ Agric Food Chem200250484084511829654
- MayerAMSHamannMTMarine pharmacology in 1999: compounds with antibacterial, anticoagulant, antifungal, anthelmintic, anti-inflammatory, antiplatelet, antiprotozoal and antiviral activities affecting the cardiovascular, endocrine, immune and nervous systems, and other miscellaneous mechanisms of actionComp Biochem Physiol C Toxicol Pharmacol2002132331533912161166
- SakaiSKomuraYNishimuraYSugawaraTHirataTInhibition of mast cell degranulation by phycoerythrin and its pigment moiety phycoerythrobilin, prepared from Porphyra yezoensisFood Sci Technol Res2011172171177
- ShinESHwangHJKimIHNamTJA glycoprotein from Porphyra yezoensis produces anti-inflammatory effects in liposaccharide-stimulated macrophages via the TLR4 signaling pathwayInt J Mol Med201128580981521701768
- CaoJWangSYaoCXuZXuXHypolipidemic effect of porphyran extracted from Pyropia yezoensis in ICR mice with high fatty dietJ Appl Phycol. Epub201565
- KitajimaHKomizuYIchiharaHImmunostimulatory effects of extract from nori (Porphyra yezoensis) in vitro and in vivoKagaku Kogaku Ronbunshu2013394359362
- KwonMJNamTJChromatographically purified porphyran from Porphyra yezoensis effectively inhibits proliferation of human cancer cellsFood Sci Biotechnol2007166873878
- ParkSJRyuJKimIHChoiYHNamTJActivation of the mTOR signaling pathway in breast cancer MCF627 cells by a peptide derived from Porphyra yezoensisOncol Rep2015331192425333576
- KlinkDSchindelhauerDLanerAGene delivery systems – gene therapy vectors for cystic fibrosisJ Cyst Fibros20043Suppl 220321215463959
- HanSMahatoRISungYKKimSWDevelopment of biomaterials for gene therapyMol Ther20002430231711020345
- de Carvalho RodriguesDAsensiKDVairoLHuman menstrual blood-derived mesenchymal cells as a cell source of rapid and efficient nuclear reprogrammingCell Transplant201221102215222422776164
- FujikuraJNakaoKSoneMInduced pluripotent stem cells generated from diabetic patients with mitochondrial DNA A3243G mutationDiabetologia20125561689169822396012
- KaneNMNowrouziAMukherjeeSLentivirus-mediated reprogramming of somatic cells in the absence of transgenic transcription factorsMol Ther201018122139214520978477
- ShaoLFengWSunYGeneration of iPS cells using defined factors linked via the self-cleaving 2A sequences in a single open reading frameCell Res200919329630619238173
- WangWWWeiWYanJReprogramming of mouse renal tubular epithelial cells to induced pluripotent stem cellsCytotherapy201315557858523415920
- MoriguchiHChungRTMiharaMSatoCGeneration of human induced pluripotent stem cells from liver progenitor cells by only small moleculesHepatology2010523116920812362
- TakahashiKTanabeKOhnukiMInduction of pluripotent stem cells from adult human fibroblasts by defined factorsCell2007131386187218035408
- TakahashiKYamanakaSInduction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factorsCell2006126466367616904174
- YuJVodyanikMASmuga-OttoKInduced pluripotent stem cell lines derived from human somatic cellsScience200731858581917192018029452
- ChoiJWJungSJKasalaDpH-sensitive oncolytic adenovirus hybrid targeting acidic tumor microenvironment and angiogenesisJ Control Release201520513414325575865
- LeeCHKimHWKimTLeeSWRecombinant adenovirus infection suppresses hTERT expression through virus-associated RNA-mediated induction of type 1 interferonBiochem Biophys Res Commun2015458483083525689720
- Rodríguez-GarcíaAGiménez-AlejandreMRojasJJSafety and efficacy of VCN-01, an oncolytic adenovirus combining fiber HSG-binding domain replacement with RGD and hyaluronidase expressionClin Cancer Res20152161406141825391696
- PendariesVGascGTiteuxMImmune reactivity to type VII collagen: implications for gene therapy of recessive dystrophic epidermolysis bullosaGene Ther201017793093720376098
- McmenaminMMWoodMJProgress and prospects: immunobiology of gene therapy for neurodegenerative disease: prospects and risksGene Ther201017444845820147982
- SvahnMGLundinKEGeRAdding functional entities to plasmidsJ Gene Med20046Suppl 1S36S4414978749
- BacharachEGonskyJLimDGoffSPDeletion of a short, untranslated region adjacent to the polypurine tract in Moloney murine leukemia virus leads to formation of aberrant 5′ plus-strand DNA ends in vivoJ Virol200074104755476410775614
- SomanathanSAAV vectors avoid inflammatory signals necessary to render transduced hepatocyte targets for destructive T cellsMol Ther201018597798220234342
- AtkinsonHChalmersRDelivering the goods: viral and non-viral gene therapy systems and the inherent limits on cargo DNA and internal sequencesGenetica2010138548549820084428
- YuGBorlonganCVOuYIn vitro non-viral Lipofectamine delivery of the gene for glial cell line-derived neurotrophic factor to human umbilical cord blood CD34+ cellsBrain Res20101325114715420171195
- GadiJRuthalaKKongKAParkHWKimMHThe third helix of the Hoxc8 homeodomain peptide enhances the efficiency of gene transfer in combination with LipofectamineMol Biotechnol2009421414818991027
- KimHKDavaaEMyungCSParkJSEnhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipidInt J Pharm20103921–214114720347025
- DavaaEKangBSHanJHCombined delivery of the adiponectin gene and rosiglitazone using cationic lipid emulsionsInt J Pharm20154831–212413025681724
- TanasienkoIVYemetsAIFiniukNSStoikaRRBlumeYBDMAEM-based cationic polymers as novel carriers for DNA delivery into cellsCell Biol Int201539324324525234366
- SlitaAVKasyanenkoNANazarovaOVDNA-polycation complexes: effect of polycation structure on physico-chemical and biological propertiesJ Biotechnol2007127467969316934901
- FilionMCPhillipsNCMajor limitations in the use of cationic liposomes for DNA deliveryInt J Pharm19981621–2159170
- DengWWCaoXWangMEfficient gene delivery to mesenchymal stem cells by an ethylenediamine-modified polysaccharide from mulberry leavesSmall20128344145122213679
- WangMDengWFuMEfficient gene transfer into rat mesenchymal stem cells with cationized Lycium barbarum polysaccharides nanoparticlesCarbohydr Polym201186415091518
- DengWFuMCaoYAngelica sinensis polysaccharide nanoparticles as novel non-viral carriers for gene delivery to mesenchymal stem cellsNanomedicine2013981181119123727125
- DengWWCaoXWangMDelivery of a transforming growth factor β-1 plasmid to mesenchymal stem cells via cationized Pleurotus eryngii polysaccharide nanoparticlesInt J Nanomedicine201271297131122457592
- CaoXDengWQuRNon-viral co-delivery of the four Yamanaka factors for generation of human induced pluripotent stem cells via calcium phosphate nanocomposite particlesAdv Funct Mater2013234354035411
- YangXTBiYYChenETFengDFOverexpression of Wnt3a facilitates the proliferation and neural differentiation of neural stem cells in vitro and after transplantation into an injured rat retinaJ Neurosci Res201492214816124254835
- DavidsonKCJamshidiPDalyRHearnMTPeraMFDottoriMWnt3a regulates survival, expansion, and maintenance of neural progenitors derived from human embryonic stem cellsMol Cell Neurosci200736340841517822920
- Lee-KubliCALuPInduced pluripotent stem cell-derived neural stem cell therapies for spinal cord injuryNeural Regen Res2015101101625788906
- LiXSaikiCIdeRStem cell therapy for central nerve system injuries: glial cells hold the keyNeural Regen Res20149131253126025221575
- NicolasGFranklinRJJefferyNDCell therapy for spinal cord injuries: what is really going on?Neuroscientist201420662363824415275
- MatsuiTAkamatsuWNakamuraMOkanoHRegeneration of the damaged central nervous system through reprogramming technology: basic concepts and potential application for cell replacement therapyExp Neurol20142605121823036600
- XuXCapitoRMSpectorMDelivery of plasmid IGF-1 to chondrocytes via cationized gelatin nanoparticlesJ Biomed Mater Res A2008841738317600330
- YangHJPeiFLeiWCaveolin-1 mediates gene transfer and cytotoxicity of polyethyleneimine in mammalian cell linesMol Cell Biochem20154021–220321125626893
- XuXCapitoRMSpectorMPlasmid size influences chitosan nanoparticle mediated gene transfer to chondrocytesJ Biomed Mater Res A200884A41038104817685397
- MacLaughlinFCMumperRJWangJChitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid deliveryJ Control Release1998561–32592729801449